Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer

Clinical Medicine Insights. Oncology
David Riseberg

Abstract

As the overall population ages, the proportion of elderly patients (aged ≥65 years) with breast cancer also increases. Studies have shown that elderly patients with hormone receptor-positive breast cancer can derive as much benefit from treatment as do younger patients, yet they remain underrepresented in clinical trials and are often undertreated in clinical practice. Treatment decisions for older patients should not be based solely on chronologic age; a patient's physiologic functioning and comorbidities must also be taken into consideration. For recurrent or metastatic disease, systemic treatment with endocrine therapies or chemotherapy may prolong a patient's life and alleviate troublesome symptoms. Resistance to therapy remains a problem in the advanced breast cancer setting, with most patients eventually becoming resistant to additional treatment. New combination regimens that target multiple pathways, such as everolimus plus exemestane, have shown efficacy in elderly patients previously resistant to endocrine therapies, and future research may need to focus on such combinations in order to improve outcomes in this patient group. A number of investigational agents are in clinical development, although few studies identify...Continue Reading

References

May 8, 1998·Critical Reviews in Oncology/hematology·J W CoeberghP P Razenberg
Apr 6, 2000·Journal of the National Cancer Institute·S G DiabG M Clark
Jun 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P E LønningG Massimini
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S DemissieT L Lash
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A HowellC Morris
Aug 22, 2002·Journal of the National Cancer Institute·Patrick J Mansky, Stephen E Straus
Mar 14, 2003·Critical Reviews in Oncology/hematology·Maria Grazia DaidoneSilvia Veneroni
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Margaret KemenyHarvey J Cohen
Mar 22, 2006·The Oncologist·Susan Burdette-Radoux, Hyman B Muss
Sep 21, 2006·Journal of the National Cancer Institute·Davide MauriJohn P A Ioannidis
May 12, 2007·Breast Cancer Research and Treatment·Jean YoonKatherine L Kahn
Dec 12, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cynthia OwusuRebecca A Silliman
Aug 30, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicholas Wilcken, Rachel Dear
Feb 6, 2009·Expert Review of Anticancer Therapy·Seema Harichand-HerdtRuth O'Regan
Jun 30, 2009·Clinical Breast Cancer·Susan J CleatorCarlo Palmieri
Aug 13, 2009·Expert Review of Anticancer Therapy·Phuong Tran, Ian S Fentiman
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John F R RobertsonMatthew J Ellis
Sep 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen JohnstonMark Pegram
Mar 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen R D Johnston
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoUNKNOWN ESMO Guidelines Working Group
Sep 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Angelo Di LeoMiguel Martin
Oct 5, 2010·Annual Review of Medicine·C Kent Osborne, Rachel Schiff
Oct 20, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproU Wedding
Dec 8, 2010·Seminars in Radiation Oncology·Beth M BeadleThomas A Buchholz
Feb 18, 2011·Expert Opinion on Pharmacotherapy·Simon SpazzapanAndrea Veronesi
Mar 19, 2011·The Oncologist·Sonal Gandhi, Sunil Verma
Mar 30, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L BiganzoliI Smith
May 20, 2011·Cancer Treatment Reviews·Marc DebledPierre Soubeyran
May 27, 2011·Seminars in Oncology·Harold J Burstein

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01698918
NCT01499160
NCT01797120
NCT00570921
NCT01610284
NCT01633060
NCT01248494
NCT01723774
NCT02028507
NCT00721409

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.